ALXN

Alexion Pharmaceuticals
ALXN

Delisted

ALXN was delisted on the 20th of July, 2021.

517 hedge funds and large institutions have $30.2B invested in Alexion Pharmaceuticals in 2016 Q1 according to their latest regulatory filings, with 47 funds opening new positions, 192 increasing their positions, 210 reducing their positions, and 70 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
517
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
14
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$198M
Puts
$161M
Net Calls
Net Calls Change

Top Buyers

1 +$260M
2 +$130M
3 +$79M
4
Millennium Management
Millennium Management
New York
+$72.9M
5
Vanguard Group
Vanguard Group
Pennsylvania
+$40.2M

Top Sellers

1 -$188M
2 -$118M
3 -$89.4M
4
Bank of New York Mellon
Bank of New York Mellon
New York
-$77M
5
Goldman Sachs
Goldman Sachs
New York
-$59.6M
Name Holding Trade Value Shares
Change
Change in
Stake
326
$824K
327
$821K
328
$807K
329
$798K
330
$791K
331
$786K
332
$782K
333
$776K
334
$771K
335
$766K
336
$749K
337
$749K
338
$743K
339
$738K
340
$723K
341
$714K
342
$703K
343
$696K
344
$696K
345
$696K
346
$695K
347
$690K
348
$690K
349
$669K
350
$654K